The rapid evolution of targeted therapies in prostate cancer has put greater emphasis on integrating guideline-concordant biomarker testing into clinical practice.Join this interactive live session led by two prostate cancer experts to explore emerging therapies, navigate guideline-concordant evidence-based treatment strategies, and review best practices for clinical decision-making. Through case-based discussion, this session will guide participants in interpreting molecular results and implementing personalized treatment decisions. This session will feature a mock clinical consult video and live Q&A enabling participants to gain real-world strategies to effectively implement patient-centered care into clinical practice. Participants will also be provided with downloadable resources, including a test-smart toolkit designed to support community oncologists in implementing biomarker testing.Don’t miss this chance to connect with colleagues and gain valuable perspectives on targeted therapy selection, patient-centered shared decision-making, and multidisciplinary collaboration to optimize biomarker testing in community settings.
Credit & MOC Details
Credit information is provided by the course provider. We recommend confirming credit eligibility with the provider or your licensing board before starting the activity.
Credit types
MOC types
FDA REMS
Qualifies for MIPS
Target Specialties
No specific specialties targeted.
Pricing
99% of listed courses are free
298 of a sample of 300 are free · 416 courses listed here.
Collected from the provider’s public pages
Specialties served/covered
- Addiction Medicine
- Adolescent Medicine
- Advanced Heart Failure & Transplant Cardiology
- Allergy & Clinical Immunology
- Anatomic & Clinical Pathology
- Cardiovascular Disease
- Communication & Shared Decision-Making
- Dermatology
- Endocrinology, Diabetes & Metabolism
- Family Medicine
- Gastroenterology
- Gastrointestinal Surgery
- General & Adult Psychiatry
- General Internal Medicine
- General Operative Anesthesia
- General Pediatrics
- General Surgery
- Geriatric Medicine
- Gynecologic Oncology
- Health Equity & Inclusion
- Hematology
- Hospital Medicine
- Infectious Disease
- Interventional Cardiology
- Interventional Radiology
- Medical Genetics & Genomics
- Medical Leadership & Administration
- Medical Oncology
- Metabolic & Bariatric Surgery
- Mood & Anxiety Disorders
- Musculoskeletal Oncology
- Nephrology
- Neurodevelopmental Disabilities
- Neurology
- Neuromuscular Medicine
- Nuclear Medicine
- Obstetrics & Gynecology
- Ophthalmology
- Pain Medicine
- Patient Education & Health Literacy
- Patient Safety & Quality Improvement
- Pediatric Hematology-Oncology
- Pediatric Neurology
- Practice Management & Ethics
- Pulmonary Disease
- Radiation Oncology
- Regional Anesthesia & Acute Pain
- Rheumatology
- Sleep Medicine
- Surgical Oncology
- Thoracic Surgery
- Transplant Hepatology
- Urological Oncology
- Urology
- Anesthesiology
- Cardio-Vascular
- Cross-Specialty
- GI & Liver
- Infectious Disease
- Internal Medicine
- Medical Subspecialties
- Neurology
- Ob/Gyn
- Oncology & Hematology
- Orthopedics
- Pain & Palliative
- Pathology & Lab
- Pediatrics
- Primary care
- Psychiatry
- Radiology
- Surgery
- Urology
- No reviews yet. Be the first to share yours.
Pricing
Free
Reported to ACCME by the provider
- Live
- Credit · Up to 1 credit
- Commercial Support
-
WhenOct 14, 2026 – Jun 30, 2027
-
PRIME Education, Inc. (PRIME®) Personalized Treatment in Advanced Prostate Cancer: Navigating the Latest Clinical Evidence in Biomarker-Driven and Combination Therapies
-
PRIME Education, Inc. (PRIME®) Precision Oncology in mHSPC: Translating Emerging Evidence Into Clinical Practice
-
PRIME Education, Inc. (PRIME®) From Trial to Treatment: Integrating Targeted Radionuclide Therapy Data Into Evidence-Based mCRPC Care
